Lisa M. Demeter
About
Lisa M. Demeter is a scholar working on Virology, Infectious Diseases and Epidemiology.
According to data from OpenAlex, Lisa M. Demeter has authored 84 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Virology, 68 papers in Infectious Diseases and 18 papers in Epidemiology. Recurrent topics in Lisa M. Demeter's work include HIV Research and Treatment (71 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (51 papers). Lisa M. Demeter is often cited by papers focused on HIV Research and Treatment (71 papers), HIV/AIDS drug development and treatment (67 papers) and HIV/AIDS Research and Interventions (51 papers). Lisa M. Demeter collaborates with scholars based in United States, Netherlands and France. Lisa M. Demeter's co-authors include Scott M. Hammer, Margaret A. Fischl, Kathleen Squires, Joseph J. Eron, Michael D. Hughes, Judith S. Currier, Judith Feinberg, Jon C. Cook, John Phair and Bach‐Yen Nguyen and has published in prestigious journals such as New England Journal of Medicine, JAMA and Genes & Development.
In The Last Decade
Lisa M. Demeter
83 papers receiving 5.8k citations
Hit Papers
Peers
Lisa M. Demeter
Sabine Yerly Switzerland
Jeffrey Chodakewitz United States
Kathleen Squires United States
Douglas L. Mayers United States
Monique Nijhuis Netherlands
Patrice Massip France
James O. Kahn United States
Suzanne Jurriaans Netherlands
Harold A. Kessler United States
Richard C. Reichman United States
Citations per year, relative to Lisa M. Demeter Lisa M. Demeter (= 1×)
peers
Sabine Yerly
Countries citing papers authored by Lisa M. Demeter
Since
Specialization
Citations
This map shows the geographic impact of Lisa M. Demeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Demeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Demeter more than expected).
Fields of papers citing papers by Lisa M. Demeter
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Lisa M. Demeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Demeter. The network helps show where Lisa M. Demeter may publish in the future.
Co-authorship network of co-authors of Lisa M. Demeter
This figure shows the co-authorship network connecting the top 25 collaborators of Lisa M. Demeter. A scholar is included among the top collaborators of Lisa M. Demeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa M. Demeter. Lisa M. Demeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Vogler, Mary, Laura Smeaton, Rodney Wright, et al.. (2013). Combination Antiretroviral Treatment for Women Previously Treated Only in Pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(5). 542–550.
2.
Hammer, Scott M., Heather J. Ribaudo, Roland Bassett, et al.. (2010). A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen. HIV Clinical Trials. 11(6). 312–324.
3.
Wyl, Viktor von, Maryam Ehteshami, Jori Symons, et al.. (2010). Epidemiological and Biological Evidence for a Compensatory Effect of Connection Domain Mutation N348I on M184V in HIV‐1 Reverse Transcriptase. The Journal of Infectious Diseases. 201(7). 1054–1062.
4.
Piekna‐Przybylska, Dorota, Carrie Dykes, Lisa M. Demeter, & Robert A. Bambara. (2010). Sequences in the U3 region of human immunodeficiency virus 1 improve efficiency of minus strand transfer in infected cells. Virology. 410(2). 368–374.
5.
Liang, Hua, et al.. (2010). The non-nucleoside reverse transcriptase inhibitor efavirenz stimulates replication of human immunodeficiency virus type 1 harboring certain non-nucleoside resistance mutations. Virology. 402(2). 228–237.
6.
Hammer, Scott M., Heather J. Ribaudo, Roland Bassett, et al.. (2010). A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen. HIV Clinical Trials. 11(6). 312–324.
7.
Volberding, Paul A., Lisa M. Demeter, Ronald J. Bosch, et al.. (2009). Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS. 23(15). 1987–1995.
8.
Demeter, Lisa M., Robin DiFrancesco, Hongyu Jiang, et al.. (2008). The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infected Patients. HIV Clinical Trials. 9(1). 61–72.
9.
Snyder‐Cappione, Jennifer, et al.. (2006). HIV-Specific Cytotoxic Cell Frequencies Measured Directly Ex Vivo by the Lysispot Assay Can Be Higher or Lower Than the Frequencies of IFN-γ-Secreting Cells: Anti-HIV Cytotoxicity Is Not Generally Impaired Relative to Other Chronic Virus Responses. The Journal of Immunology. 176(4). 2662–2668.
10.
Luque, Amneris E., Susan Messing, Christopher Lane, et al.. (2006). Prevalence of Human Papillomavirus Genotypes and Related Abnormalities of Cervical Cytological Results among HIV‐1–Infected Women in Rochester, New York. The Journal of Infectious Diseases. 194(4). 428–434.
11.
Dykes, Carrie, Mini Balakrishnan, Vicente Planelles, et al.. (2004). Identification of a preferred region for recombination and mutation in HIV-1 gag. Virology. 326(2). 262–279.
12.
Haubrich, Richard & Lisa M. Demeter. (2001). Clinical Utility of Resistance Testing: Retrospective and Prospective Data Supporting Use and Current Recommendations. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26 Suppl 1. S51–S59.
13.
Evans, Thomas G., William Bonnez, Robert C. Rose, et al.. (2001). A Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult Volunteers. The Journal of Infectious Diseases. 183(10). 1485–1493.
14.
Morse, Gene D., Richard C. Reichman, Margaret A. Fischl, et al.. (2000). Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. Antiviral Research. 45(1). 47–58.
15.
Hirsch, Martin, Brian Conway, Richard T. D'Aquila, et al.. (1998). Antiretroviral Drug Resistance Testing in Adults With HIV Infection. JAMA. 279(24). 1984–1984.
16.
Demeter, Lisa M., Gene D. Morse, Peter Gerondelis, et al.. (1997). HIV-1 Drug Susceptibilities and Reverse Transcriptase Mutations in Patients Receiving Combination Therapy with Didanosine and Delavirdine. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(2). 136–144.
17.
Welles, Seth L., J. Brooks Jackson, Belinda Yen‐Lieberman, et al.. (1996). Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine Therapy. The Journal of Infectious Diseases. 174(4). 696–703.
18.
Frenkel, Lisa M., Larry E. Wagner, Lisa M. Demeter, et al.. (1995). Effects of Zidovudine Use During Pregnancy on Resistance and Vertical Transmission of Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 20(5). 1321–1326.
19.
Demeter, Lisa M., et al.. (1995). Development of Zidovudine Resistance Mutations in Patients Receiving Prolonged Didanosine Monotherapy. The Journal of Infectious Diseases. 172(6). 1480–1485.
20.
Reichman, Richard C., Gene D. Morse, Lisa M. Demeter, et al.. (1995). Phase I Study of Atevirdine, a Nonnucleoside Reverse Transcriptase Inhibitor, in Combination with Zidovudine for Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 171(2). 297–304.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sabine Yerly Breakdown of academic impact, for papers by Jeffrey Chodakewitz Breakdown of academic impact, for papers by Kathleen Squires Breakdown of academic impact, for papers by Douglas L. Mayers Breakdown of academic impact, for papers by Monique Nijhuis Breakdown of academic impact, for papers by Patrice Massip Breakdown of academic impact, for papers by James O. Kahn Breakdown of academic impact, for papers by Suzanne Jurriaans Breakdown of academic impact, for papers by Harold A. Kessler Breakdown of academic impact, for papers by Richard C. Reichman